GI & Endoscopy

The following GI companies have made headlines this week, with Japan-based Takeda Pharmaceuticals facing the revival of an antitrust case.

Brij M. Dewan, MD, is a gastroenterologist and founder of Kalamazoo (Mich.) Gastroenterology.

A study published in PLOS One researched vitamin D's effect in children with irritable bowel syndrome.

Japan-based Takeda donated $1 million to Cambridge, Mass.-based Koch Institute for integrative cancer research.

After the recent flood of duodenoscope-related deaths, Eric Chaffin, an attorney at New York City-based Chaffin Luhana, penned a column for the Legal Examiner examining if disposable duodenoscopes could limit infection risks. 

European Union-based OncoTrack researchers possibly discovered biomarkers that could predict two drugs's effectiveness in treating common bowel cancer, News-Medical reports.

David Carron, MD, is a gastroenterologist at Waukesha, Wis.-based GI Associates.

Parsippany-Troy Hills, NJ-based Allergan finished the 2016 fiscal year with a bang with higher than expected earnings and revenues, The Cerbat Gem reports.

The International Association of HealthCare Professionals included Democleia Panagou Gottesman, MD, in its "Leading Physicians of the World" publication.

Florence, S.C.-based McLeod Health added Jeffrey Dorociak, MD., to its Florence (S.C.) Gastroenterology Associates practice, SCNow reports.